Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the plant-based vaccines market grown over the years?

The market size for plant-based vaccines has seen substantial growth in recent years. Its value is predicted to increase from $1.66 billion in 2024 to $1.83 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.2%. Factors contributing to past growth include the challenges associated with traditional vaccine production, the demand for cost-effective vaccine production methods, the rise of plant molecular farming, decreased allergenic potential, and applications in synthetic biology.

What Is the forecasted market size and growth rate for the plant-based vaccines market?

In the coming years, a swift expansion is projected for the plant-based vaccines market, which is estimated to reach $2.79 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.1%. The growth anticipated within this period can be traced back to readiness for pandemics, international health protection, broadened vaccine applications, and incorporation within the pharmaceutical industry. The key trends for this period are likely to be the progression of technology in plant biotechnology, environmental viability, artificial intelligence incorporation, and machine learning integration.

Get your plant-based vaccines market report here!

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

What are the major factors driving growth in the plant-based vaccines market?

The rampant spread of infectious diseases is projected to fuel the expansion of the plant-based vaccine market in the future. These diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, and parasites. Utilized in both traditional and modern therapeutics to treat various conditions, including infectious diseases, plant-based vaccines have the potential to yield secure, effective, stable and cost-effective preventatives, vaccines, and treatments. For instance, the World Health Organization, a Switzerland-based international health body, estimated in its Global Tuberculosis Report released in October 2022 that there were approximately 10.6 million cases of tuberculosis (TB) globally, with a rate of 134 cases per 100,000 individuals. The Southeast Asia region recorded the highest number of TB cases, amounting to 45% of the global total, with Africa accounting for 23%. As a result, the significant prevalence of infectious diseases is stimulating the advancement of the plant-based vaccine market.

What key areas define the segmentation of the global plant-based vaccines Market?

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

What are the top market players propelling the growth of the plant-based vaccines industry?

Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

What are the key trends shaping the future of the plant-based vaccines market?

Product enhancement is becoming a major trend in the plant-based vaccine industry. Established organizations in this industry are highly focused on producing unique products to maintain their market foothold. For example, in February 2022, Medicago Inc., a bio-pharmaceutical firm based in Canada, together with GSK PLC, a biotechnology and pharmaceutical company based in the UK, declared that Health Canada gave its approval to COVIFENZ, the COVID-19 vaccine. COVIFENZ is the first-ever plant-based virus-like particles [VLP], recombinant, adjuvanted vaccine developed for COVID-19. It uses the COVID-19-like particle (CoVLP) technology and comprises recombinant spike (S) glycoproteins crafted as virus-like particles (VLPs).

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12144

What regions are dominating the plant-based vaccines market growth?

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Automotive Cables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-cables-global-market-report

Automobile Rental And Leasing Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery

https://www.thebusinessresearchcompany.com/report/automobile-rental-and-leasing-market

Electric Motor And Generator Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electric-motor-and-generator-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: